Jason Luke

Professor of medicine, associate director of clinical research, and the director of the Phase 1 IDDC Program at the University of Pittsburgh's Hillman Cancer Center. Discusses key advancements in melanoma and skin cancers.

Best podcasts with Jason Luke

Ranked by the Snipd community

Jun 27, 2025 • 27min

Immunotherapy at ASCO25: Drug Development, Melanoma Treatment, and More

Jason Luke, a professor of medicine and director at the University of Pittsburgh's Hillman Cancer Center, dives into cutting-edge advancements in melanoma and skin cancer treatments. He discusses the disappointing results of the RELATIVITY-098 trial, which showed no significant survival benefit from a combination therapy. They explore innovative mRNA treatments as potential new standards and highlight breakthroughs in T cell bispecifics and CAR-T therapies, shedding light on the future of immunotherapy in oncology.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app